Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.395
+0.005 (0.36%)
Jun 3, 2026, 3:40 PM EDT - Market open
Humacyte Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Humacyte stock has a consensus rating of "Buy" and an average price target of $1.90. The average 1-year stock price forecast is 36.20% higher than the current stock price, while the lowest is $1.00 (-28.32%) and the highest is $3.00 (+115.05%).
Price Target: $1.90 (+36.20%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Humacyte stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 4 | 4 | 3 | 3 |
| Buy | 1 | 1 | 2 | 2 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark Co. | Benchmark Co. | Buy Maintains $1 → $2 | Buy | Maintains | $1 → $2 | +43.37% | Jun 1, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $3 | Buy | Reiterates | $3 | +115.05% | May 26, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $1 | Hold | Maintains | $1 | -28.32% | May 14, 2026 |
| Barclays | Barclays | Buy Reiterates $1.5 | Buy | Reiterates | $1.5 | +7.53% | May 14, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $1 → $1.5 | Buy | Reiterates | $1 → $1.5 | +7.53% | May 13, 2026 |
Financial Forecast
Revenue This Year
6.50M
from 2.04M
Increased by 219.07%
Revenue Next Year
24.83M
from 6.50M
Increased by 281.88%
EPS This Year
-0.34
from -0.26
EPS Next Year
-0.28
from -0.34
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.4M | ||
| Avg | 6.5M | ||
| Low | 4.4M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 313.8% | ||
| Avg | 219.1% | ||
| Low | 115.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.16 | ||
| Avg | -0.34 | ||
| Low | -0.43 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.